One direct listing and four SPACs debuted this week, while five IPOs and four SPACs submitted filings. Japanese software firm Advasa Holdings (ADBT) completed its direct listing on the Nasdaq. The company develops and licenses earned wage access (EWA)...read more
Rainier Acquisition, a blank check company targeting life sciences, raised $75 million by offering 7.5 million units at $10. Each unit consists of one share of common stock, and one-fourth of a warrant to purchase a share, exercisable at $11.50. Rainier...read more
Six IPOs and five SPACs priced this week. Two IPOs and eight SPACs submitted filings. Cardiovascular disease biotech Braveheart Bio (BRVE) upsized and priced above the range, raising $383 million at a $1.6 billion market cap. Its lead candidate, BHB-1893, is ...read more
Rainier Acquisition, a blank check company target life sciences, filed on Thursday with the SEC to raise up to $75 million in an initial public offering. The company plans to raise $75 million by offering 7.5 million units at $10. Each unit consists of one...read more
US IPO Weekly Recap: Aggreko and four others file papers ahead of Labor Day holiday
One direct listing and four SPACs debuted this week, while five IPOs and four SPACs submitted filings. Japanese software firm Advasa Holdings (ADBT) completed its direct listing on the Nasdaq. The company develops and licenses earned wage access (EWA)...read more
SPAC Rainier Acquisition prices $75 million IPO, targeting life sciences
Rainier Acquisition, a blank check company targeting life sciences, raised $75 million by offering 7.5 million units at $10. Each unit consists of one share of common stock, and one-fourth of a warrant to purchase a share, exercisable at $11.50. Rainier...read more
US IPO Weekly Recap: August kicks off with flurry of biotech IPOs
Six IPOs and five SPACs priced this week. Two IPOs and eight SPACs submitted filings. Cardiovascular disease biotech Braveheart Bio (BRVE) upsized and priced above the range, raising $383 million at a $1.6 billion market cap. Its lead candidate, BHB-1893, is ...read more
SPAC Rainier Acquisition files for a $75 million IPO, targeting life sciences
Rainier Acquisition, a blank check company target life sciences, filed on Thursday with the SEC to raise up to $75 million in an initial public offering. The company plans to raise $75 million by offering 7.5 million units at $10. Each unit consists of one...read more